Information Provided By: 
Fly News Breaks for July 14, 2016
HOLX
Jul 14, 2016 | 08:47 EDT
Canaccord conducted its second 3D tomo survey and the returns suggested Hologic is well positioned to expand its leading market share position and continue converting customers from 2D to 3D tomosynthesis. The firm said they see a faster adoption than expected and so reiterated a Buy rating and $45 price target on Hologic shares.
News For HOLX From the Last 2 Days
There are no results for your query HOLX
